VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,098,000 | -69.2% | 436,000 | -38.0% | 0.18% | -63.0% |
| Q3 2018 | $13,309,000 | -3.2% | 703,425 | 0.0% | 0.49% | -14.2% |
| Q2 2018 | $13,745,000 | +4.0% | 703,425 | 0.0% | 0.57% | -7.9% |
| Q1 2018 | $13,217,000 | +13.2% | 703,425 | 0.0% | 0.62% | +1.6% |
| Q4 2017 | $11,677,000 | +1.0% | 703,425 | +25.3% | 0.61% | -7.0% |
| Q3 2017 | $11,560,000 | +330.1% | 561,425 | +87.1% | 0.66% | +292.2% |
| Q2 2017 | $2,688,000 | -32.3% | 300,000 | 0.0% | 0.17% | -36.5% |
| Q1 2017 | $3,972,000 | +3.9% | 300,000 | 0.0% | 0.26% | +5.6% |
| Q4 2016 | $3,822,000 | +6.1% | 300,000 | 0.0% | 0.25% | +13.2% |
| Q3 2016 | $3,603,000 | +9.3% | 300,000 | 0.0% | 0.22% | +8.9% |
| Q2 2016 | $3,297,000 | +25.9% | 300,000 | 0.0% | 0.20% | +38.4% |
| Q1 2016 | $2,619,000 | -52.2% | 300,000 | +20.0% | 0.15% | -46.7% |
| Q4 2015 | $5,475,000 | – | 250,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |